(CWS) AdvisorShares Focused - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00768Y5603 • Mid-Cap Blend

CWS: Stocks, Preferred Stocks, American Depositary Receipts

The AdvisorShares Focused Equity ETF (NYSE ARCA:CWS) is designed to capture returns by concentrating its investments in a select group of U.S. exchange-listed equity securities. The fund allocates at least 80% of its net assets to equity securities, including common stocks, preferred shares, and American Depositary Receipts (ADRs). The portfolio is constructed using a proprietary model developed by Edward J. Elfenbein, which emphasizes companies with strong financial fundamentals, consistent operating performance, and high-quality earnings. This approach aims to identify firms with durable business models and stable cash flows.

As of the latest data, the ETF has assets under management (AUM) of $180.55 million, with an average trading volume of 10,205 shares over the past 20 days. The fund is classified as a mid-cap blend ETF, targeting companies with market capitalizations typically falling within the mid-cap range. It trades on the NYSE ARCA under the ticker symbol CWS, with a last price of $66.50. The funds performance is also monitored through key technical indicators, including its 20-day, 50-day, and 200-day simple moving averages (SMA), which stand at 66.98, 66.57, and 66.20, respectively. The Average True Range (ATR) of 0.81 indicates moderate price volatility.

3-Month Forecast: Based on the current technical and fundamental data, the ETF is expected to experience a period of consolidation. The SMA 20 and SMA 50 are slightly above the last price, suggesting near-term resistance levels. However, the SMA 200, which is below the current price, may act as a support level if the price retraces. The ATR of 0.81 suggests that price fluctuations will likely remain contained, with a potential trading range between $65.69 and $67.31 over the next three months. The funds AUM of $180.55 million reflects moderate investor interest, which could support liquidity. Overall, the ETF is expected to maintain its current trajectory, with upside potential if it breaks above the SMA 50. Investors should monitor volume trends, as the relatively low average daily volume of 10,205 shares could lead to larger price swings on high-impact news or market movements.

Additional Sources for CWS ETF

CWS ETF Overview

Market Cap in USD 178m
Category Mid-Cap Blend
TER 0.84%
IPO / Inception 2016-09-20

CWS ETF Ratings

Growth Rating 69.1
Fundamental -
Dividend Rating 45.7
Rel. Strength -2.17
Analysts -
Fair Price Momentum 67.53 USD
Fair Price DCF -

CWS Dividends

Dividend Yield 12m 0.57%
Yield on Cost 5y 1.13%
Annual Growth 5y 25.93%
Payout Consistency 62.0%

CWS Growth Ratios

Growth Correlation 3m -54.3%
Growth Correlation 12m 27.9%
Growth Correlation 5y 91.3%
CAGR 5y 14.88%
CAGR/Max DD 5y 0.60
Sharpe Ratio 12m 0.32
Alpha -0.29
Beta 0.672
Volatility 23.22%
Current Volume 8.7k
Average Volume 20d 8.9k
What is the price of CWS stocks?
As of May 09, 2025, the stock is trading at USD 67.18 with a total of 8,702 shares traded.
Over the past week, the price has changed by +3.16%, over one month by +13.15%, over three months by -0.54% and over the past year by +8.24%.
Is AdvisorShares Focused a good stock to buy?
Yes. Based on ValueRay Analyses, AdvisorShares Focused (NYSE ARCA:CWS) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.10 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CWS as of May 2025 is 67.53. This means that CWS is currently overvalued and has a potential downside of 0.52%.
Is CWS a buy, sell or hold?
AdvisorShares Focused has no consensus analysts rating.
What are the forecast for CWS stock price target?
According to ValueRays Forecast Model, CWS AdvisorShares Focused will be worth about 75.3 in May 2026. The stock is currently trading at 67.18. This means that the stock has a potential upside of +12.01%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 75.3 12%